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Adverse reactions to food are a frequently discussed
cause of urticaria. In acute urticaria 63% of patients
suspect food as the eliciting factor; however, this
cannot be con®rmed in prospective studies. In adults
the rate of type I allergic reactions is below 1%,
although in children the percentage appears to be
higher. Also in chronic urticaria type I allergic reac-
tions play only a minor role as an eliciting factor.
The same holds for the physical urticarias. The role
of pseudoallergic reactions has not been investigated
for all types of urticaria, but apparently they are not
important in physical urticarias; however, in acute
urticaria pseudoallergic reactions against NSAID are
responsible for approximately 9% of cases, and in a
subset of patients with chronic urticaria a diet low in
pseudoallergens has been proven to be bene®cial in
several studies, with response rates observed in more
than 55% of patients. Double-blind, placebo-con-
trolled challenge tests have shown that arti®cial food
additives are not only to blame, with the majority of
reactions being traced back to naturally occuring
pseudoallergens in food. Key words: angioderma/hyper-
sensitivity/intolerance/wheal. Journal of Investigative
Dermatology Symposium Proceedings 6:132±134, 2001
B
oth allergic and pseudoallergic reactions have fre-
quently been discussed as possible eliciting factors in
various forms of urticaria; however, only a limited
number of controlled studies are available. Epidemio-
logic studies are dif®cult to perform for several reasons.
First, in urticaria not only must the elicitation of whealing by one
factor be considered, but also the augmentation of pre-existing low
level disease activity by allergens or pseudoallergens. Second, the
diagnosis of allergy and pseudoallergy is complicated. Whereas in
type I allergic reactions skin and blood tests are available, skin tests
especially may lead to falsely positive answers in urticaria patients
due to unspeci®c whealing. The gold standard remains the double-
blind, placebo-controlled allergen challenge. In pseudoallergic
reactions the situation is even more complicated as to date no
skin or in vitro test is available. The clinical symptoms cannot be
distinguished from a type I allergic reaction; however, for
provocation tests it must be remembered that in contrast to type
I allergies, symptoms occur frequently with a latency of more than
4 h and symptoms cease frequently only after an omission of the
suspected pseudoallergen for more than 10±14 d. The latter
observation is especially important in comparing different studies
using elimination diets.
ACUTE URTICARIA
Acute urticaria is a frequent disease affecting approximately 15%±
23% of the population at least once in their life time (Henz et al,
1998). Asked for the eliciting cause, most patients suspect an
allergy against food (63%) (Zuberbier et al, 1996); however, this
assumption could not be con®rmed in two studies (Aoki et al,
1994; Zuberbier et al, 1996) where food allergy could only give
evidence for 0 of 50 and 1 of 109 patients, respectively. In
childhood type I allergy appears to be of higher importance, with a
rate of 15% reported in the age group of 6 mo to 16 y (Kauppinen
et al, 1984).
Pseudoallergic reactions against food were not reported in any of
the studies, but pseudoallergic reactions against NSAID were
reported to be the second most frequent cause, responsible for 9%
of cases (Zuberbier et al, 1996).
CHRONIC URTICARIA
Similar to acute urticaria, type I allergic reactions are only rarely
responsible for the development of chronic urticaria (Juhlin, 1981;
Zuberbier et al, 1995). The most likely subgroup of chronic
urticaria where type I allergy can be suspected are those patients
who suffer from intermittent attacks of whealing lasting for a few
hours shortly after the ingestion of food. In contrast, in patients
with chronic continuous urticaria with daily whealing the type I
allergen is very unlikely to be responsible. In this subset of patients
pseudoallergic reactions against food and food additives have been
repeatedly discussed in the past apart from infectious or
autoimmune etiology. A survey of studies is summarized in
Table I; however, only a few studies have used the gold standard
of double-blind, placebo-controlled food challenge tests. Results
may also differ due to the differences in study populations and study
conditions. Some studies have included not only patients with
chronic urticaria but also patients with physical urticaria. In other
cases elimination diets were only used for a short period of a few
days. Our own results (Zuberbier et al, 1995) show that in those
patients improving on a diet low in pseudoallergens, 30% show
a decrease of symptoms after only 10±14 d on the diet.
Approximately 50% of patients do not show a total clearance of
symptoms but have an improvement in disease intensity, pointing
to other possible cofactors involved in the pathogenesis. In some
countries referrals to specialists are only possible in severe cases. In
our own study unselected patients with chronic continuous
urticaria were included who had not previously received a
diagnostic work-up. In this group a high incidence of pseudo-
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allergic reactions against food was seen. These results were only
recently con®rmed by Pigatto and Valsecchi (2000), who inves-
tigated a group of 202 patients with chronic urticaria using the same
diet. In this study 126 patients improved on the diet, whereas 35
patients did not show any bene®t from the diet and 41 patients
dropped out. In both studies reactions to food additives were only
seen in a minority of patients (19% and 37%, respectively), which
points at the relevance of naturally occuring pseudoallergens.
Especially aromatic compounds found in vegetables and food
appear to be important. An open provocation test in 31 chronic
urticaria patients showed that 71% of patients responding to a low
pseudoallergen diet reacted to tomatoes, and 44% to distillates of
tomatoes containing aromatic compounds free of protein and
salicylic acid. In contrast less than 7% reacted to histamine, protein,
and salicylate-rich residue (Pfrommer et al, 1996).
During the last few years very little knowledge has been gained
about the mechanisms of pseudoallergic reactions against food.
Synergism with other eliciting factors might be of importance; one
possibility appears to be the gastric mucosa. Initial results show that
the gastric but not the intestinal permeability is decreased in patients
with chronic continuous urticaria bene®ting from a pseudoaller-
gen-free diet, and this pathologic permeability is restored after 3 wk
of diet (BuÈhner et al, 1998). In another study we investigated the
occurence of anti-FceRI-a autoantibodies, which have been
described to be of pathophysiologic relevance in some patients
with urticaria (Hide et al, 1993; Fiebiger et al, 1998). In our studies
these autoantibodies were found at the same frequency as described
earlier, but they could be found both in patients with idiopathic
chronic urticaria (seven of 22) and in patients with pseudoallergy
against food whose symptoms cleared on stopping the diet (six of
17) (Zuberbier et al, 2000). There are two possible explanations for
these ®ndings. First, the FceRI-a autoantibodies are not of
pathophysiologic relevance in all patients with urticaria; and
second, a synergism between the autoantibodies and other eliciting
stimuli, e.g., food, is necessary for the appearance of clinical
symptoms in some patients. Future research in this ®eld is necessary
to answer this question.
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Table I. Survey of studies on the role of food in the pathogenesis of urticaria
Author(s)
Number of
patients
investigated
Number of positive
reactions to
food additives Method of provocation Response to diet
Warin and Smith (1976) 111 59.5% (incl. ASS) single-blind, placebo-controlled
(antihistamine treatment)
75%a
Genton et al (1985) 17 88.2% (incl. ASS) single-blind 93.3%a
Michaelsson and Juhlin (1973) 52 75% (incl. ASS) single-blind 81.3% free of symptomsa
6.3% clear improvementa
Thune and Granhold (1975) 100 62% (incl. ASS) single-blind 80.6% clear improvementa
19.4% spontaneous clearancea
WuÈthrich and Fabro (1981) 620 26.6.% (incl. ASS) single-blind > 60% clear improvement
a
Juhlin (1981) 330 31% single-blind no data
Ortolani et al (1984) 70 59.6% (incl. ASS) single-blind, placebo-controlled no data
Rudzki (1980) 158 31.6% no data
Ros et al (1976) 75 follow-up study 24% free of symptomsa
57% clear improvementa
Verschave et al (1983) 67 none 55% of all patients
Gibson and Clancy (1980) 76 up to 54% single-blind, placebo-controlled of all patients:
71.1% free of symptoms
19.7% clear improvement
9.2% refused diet
Kirchhof et al (1982) 100 39% double-blind, placebo-controlled 44%a
Suprananiam and Warner (1986) 43 24% double-blind, placebo-controlled 87.5%a
Zuberbier et al (1995) 67 19% double-blind, placebo-controlled 73% of all patients
Pigatto and Valsecchi (2000) 202 of a
total group
of 348
37.3% double-blind, placebo-controlled 62.4% clear improvement
17.3% no bene®t
20.3% discontinued diet
aNumber referring to the group of patients put on diet after positive reactions.
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